Skip to main content
SpringerLink
Log in

Rheumatological Complications Following COVID-19

  • Chapter
  • First Online:
Post COVID-19 Complications and Management

  • 306 Accesses

Abstract

Global data suggest that around 10% of Covid-19 patients remain unwell even after 3 months of getting infection and children are no exception. Several systemic autoimmune and inflammatory diseases, irrespective of severity of infection, have been reported in patients during post-Covid-19 period. It has been hypothesized that hyperactivation of immune system, molecular mimicry and activation of neutrophil extracellular trap formation contribute to development of post-Covid-19 autoimmunity. Management of systemic autoimmune and inflammatory diseases may require nonsteroidal anti-inflammatory drugs, diseases-modifying antirheumatic drugs and immunosuppressives along with interdisciplinary supportive care depending on the type and severity of the clinical condition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81:e4–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Sapkota HR, Nune A. Long COVID from rheumatology perspective—a narrative review. Clin Rheumatol. 2021;41(2):337–48. https://doi.org/10.1007/s10067-021-06001-1.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Petersen MS, Kristiansen MF, Hanusson KD, Danielsen ME, Steig BÁ, Gaini S, Strøm M, Weihe P. Long COVID in the Faroe Islands—a longitudinal study among non-hospitalized patients. Clin Infect Dis. 2020;73(11):e4058–63.

    Article  Google Scholar 

  4. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. MedRxiv. 2021; https://doi.org/10.1101/2021.01.27.21250617.

  5. Lyons-Weiler J. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. J Transl Autoimmun. 2020;3:100051.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Gasparotto M, Framba V, Piovella C, Doria A, Iaccarino L. Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol. 2021;40:3357–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kocyigit BF, Akyol A. Reactive arthritis after COVID-19: a case-based review. Rheumatol Int. 2021;41:2031–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Derksen VFAM, Kissel T, Lamers-Karnebeek FBG, van der Bijl AE, Venhuizen AC, Huizinga TWJ, Toes REM, Roukens AHE, van der Woude D. Onset of rheumatoid arthritis after COVID-19: coincidence or connected? Ann Rheum Dis. 2021;80(8):1096–8. https://doi.org/10.1136/annrheumdis-2021-219859.

    Article  CAS  PubMed  Google Scholar 

  9. Tamborrini G, Micheroli R. [CME rheumatology 23/answers: rheumatoid arthritis following COVID-19/SARS-CoV-2 infection]. Praxis. 2021;110:375–6.

    Google Scholar 

  10. Perrot L, Hemon M, Busnel J-M, Muis-Pistor O, Picard C, Zandotti C, Pham T, Roudier J, Desplat-Jego S, Balandraud N. First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021;3:e6–8.

    Article  PubMed  Google Scholar 

  11. Ben-Chetrit E, Ben-Chetrit E. Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection. Clin Exp Rheumatol. 2021;39:1410–2.

    Article  PubMed  Google Scholar 

  12. Chan KH, Farouji I, Abu Hanoud A, Slim J. Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19). Am J Emerg Med. 2020;38:1548.e1–3.

    Article  Google Scholar 

  13. Batur EB, Korez MK, Gezer IA, Levendoglu F, Ural O. Musculoskeletal symptoms and relationship with laboratory findings in patients with COVID-19. Int J Clin Pract. 2021;75:e14135.

    Article  CAS  PubMed  Google Scholar 

  14. Saud A, Naveen R, Aggarwal R, Gupta L. COVID-19 and myositis: what we know so far. Curr Rheumatol Rep. 2021;23:63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Hassan M, Ullah Khan N, Iqbal Chaudhary M, Jan Z, Majid Rajput H, Susan Dewey R, Badshah M. Neurological complications of SARS-CoV-2: a single-center case series. Brain Hemorrhages. 2021;2(4):161–4. https://doi.org/10.1016/j.hest.2021.09.004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Deeb A, Kumar PC, Sakrani N, Trehan RK, Papinenei VR. Neurological presentations of COVID-19: characteristic features in a case series of hospitalized patients from Abu Dhabi, UAE. BioMed Res Int. 2021;2021:5822259.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Gokhale Y, Patankar A, Holla U, Shilke M, Kalekar L, Karnik ND, Bidichandani K, Baveja S, Joshi A. Dermatomyositis during COVID-19 pandemic (a case series): is there a cause effect relationship? J Assoc Physicians India. 2020;68:20–4.

    PubMed  Google Scholar 

  18. Rebendenne A, Valadão ALC, Tauziet M, et al. SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells. J Virol. 2021;95(8):e02415–20.

    Article  CAS  PubMed Central  Google Scholar 

  19. Aschman T, Schneider J, Greuel S, et al. Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. JAMA Neurol. 2021;78:948–60.

    Article  PubMed  Google Scholar 

  20. Dalakas MC. Unconvincing evidence of SARS-CoV-2-associated myositis in autopsied muscles. JAMA Neurol. 2021;79(1):92–3. https://doi.org/10.1001/jamaneurol.2021.4336.

    Article  Google Scholar 

  21. Mehan WA, Yoon BC, Lang M, Li MD, Rincon S, Buch K. Paraspinal myositis in patients with COVID-19 infection. AJNR Am J Neuroradiol. 2020;41:1949–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Armstrong BK, Murchison AP, Bilyk JR. Suspected orbital myositis associated with COVID-19. Orbit. 2021;40(6):532–5. https://doi.org/10.1080/01676830.2021.1962366.

    Article  PubMed  Google Scholar 

  23. Almadani M, Shiferson A, Swearingen B, Shih M, Jacob T, Rhee R. Compartment syndrome secondary to viral myositis as initial presentation in COVID-19 patient. J Vasc Surg Cases Innov Tech. 2020;6:524–7.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kumar NB. Does COVID-19-related cachexia mimic cancer-related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management. J Cachexia Sarcopenia Muscle. 2021;12:519–22.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Bahouth S, Chuang K, Olson L, Rosenthal D. COVID-19 related muscle denervation atrophy. Skelet Radiol. 2021;50:1717–21.

    Article  CAS  Google Scholar 

  26. Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020;50:499–511.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Colmenero I, Santonja C, Alonso-Riaño M, Noguera-Morel L, Hernández-Martín A, Andina D, Wiesner T, Rodríguez-Peralto JL, Requena L, Torrelo A. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol. 2020;183:729–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kumar G, Pillai S, Norwick P, Bukulmez H. Leucocytoclastic vasculitis secondary to COVID-19 infection in a young child. BMJ Case Rep. 2021;14:e242192.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Kashi M, Jacquin A, Dakhil B, Zaimi R, Mahé E, Tella E, Bagan P. Severe arterial thrombosis associated with Covid-19 infection. Thromb Res. 2020;192:75–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Quintana-Castanedo L, Feito-Rodríguez M, Fernández-Alcalde C, Granados-Fernández M, Montero-Vega D, Mayor-Ibarguren A, de Lucas-Laguna R. Concurrent chilblains and retinal vasculitis in a child with COVID-19. J Eur Acad Dermatol Venereol. 2020;34:e764–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Vulliamy P, Jacob S, Davenport RA. Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19. Br J Haematol. 2020;189:1053–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Menter T, Haslbauer JD, Nienhold R, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77:198–209.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Pinto AA, Carroll LS, Nar V, Varatharaj A, Galea I. CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19. Neurol Neuroimmunol Neuroinflamm. 2020;7:e813.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Camprodon Gómez M, González-Cruz C, Ferrer B, Barberá MJ. Leucocytoclastic vasculitis in a patient with COVID-19 with positive SARS-CoV-2 PCR in skin biopsy. BMJ Case Rep. 2020;13:e238039.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Kant S, Raman G, Damera P, Antiochos B, Seo P, Geetha D. Characteristics and outcomes of COVID-19 in patients with antineutrophil cytoplasmic antibody-associated vasculitis. Kidney Int Rep. 2021;6:806–9.

    Article  PubMed  Google Scholar 

  36. Uppal NN, Kello N, Shah HH, Khanin Y, De Oleo IR, Epstein E, Sharma P, Larsen CP, Bijol V, Jhaveri KD. De novo ANCA-associated vasculitis with glomerulonephritis in COVID-19. Kidney Int Rep. 2020;5:2079–83.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Lecler A, Villeneuve D, Vignal C, Sené T. Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic. Ann Rheum Dis. 2020;80(6):e89.

    Article  PubMed  Google Scholar 

  38. Luther R, Skeoch S, Pauling JD, Curd C, Woodgate F, Tansley S. Increased number of cases of giant cell arteritis and higher rates of ophthalmic involvement during the era of COVID-19. Rheumatol Adv Pract. 2020;4:rkaa067.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Parreau S, Liozon E, Ly K-H, Fauchais A-L, Hantz S. High incidence of giant cell arteritis during the COVID-19 pandemic: no causal relationship but possible involvement of stress. Clin Exp Rheumatol. 2021;39(Suppl 129):199–200.

    Article  PubMed  Google Scholar 

  40. Mehta P, Sattui SE, van der Geest KSM, Brouwer E, Conway R, Putman MS, Robinson PC, Mackie SL. Giant cell arteritis and COVID-19: similarities and discriminators. A systematic literature review. J Rheumatol. 2021;48:1053–9.

    Article  CAS  PubMed  Google Scholar 

  41. Harzallah I, Debliquis A, Drénou B. Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost. 2020;18:2064–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Fan BE, Ng J, Chan SSW, et al. COVID-19 associated coagulopathy in critically ill patients: a hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis. J Thromb Thrombolysis. 2021;51:663–74.

    Article  CAS  PubMed  Google Scholar 

  43. Connell NT, Battinelli EM, Connors JM. Coagulopathy of COVID-19 and antiphospholipid antibodies. J Thromb Haemost. 2020; https://doi.org/10.1111/jth.14893.

  44. Favaloro EJ, Henry BM, Lippi G. COVID-19 and Antiphospholipid antibodies: time for a reality check? Semin Thromb Hemost. 2021;48(1):72–92. https://doi.org/10.1055/s-0041-1728832.

    Article  CAS  PubMed  Google Scholar 

  45. Schofield JR. Persistent antiphospholipid antibodies, mast cell activation syndrome, postural orthostatic tachycardia syndrome and post-COVID syndrome: 1 year on. Eur J Case Rep Intern Med. 2021;8:002378.

    PubMed  PubMed Central  Google Scholar 

  46. Johansson M, Ståhlberg M, Runold M, Nygren-Bonnier M, Nilsson J, Olshansky B, Bruchfeld J, Fedorowski A. Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep. 2021;3:573–80.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Bertin D, Kaphan E, Weber S, Babacci B, Arcani R, Faucher B, Ménard A, Brodovitch A, Mege JL, Bardin N. Persistent IgG anticardiolipin autoantibodies are associated with post-COVID syndrome. Int J Infect Dis. 2021;113:23–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Wong SW, Fan BE, Huang W, Chia YW. ST-segment elevation myocardial infarction in post-COVID-19 patients: a case series. Ann Acad Med Singap. 2021;50:425–30.

    Article  PubMed  Google Scholar 

  49. Ramos-Casals M, Brito-Zerón P, Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol. 2021;17:315–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Zacharias H, Dubey S, Koduri G, D’Cruz D. Rheumatological complications of Covid 19. Autoimmun Rev. 2021;20:102883.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Slimani Y, Abbassi R, El Fatoiki F-Z, Barrou L, Chiheb S. Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient. J Med Virol. 2021;93:1184–7.

    Article  CAS  PubMed  Google Scholar 

  52. Zamani B, Moeini Taba S-M, Shayestehpour M. Systemic lupus erythematosus manifestation following COVID-19: a case report. J Med Case Rep. 2021;15:29.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Shayestehpour M, Zamani B. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur Rev Med Pharmacol Sci. 2020;24:11474.

    CAS  PubMed  Google Scholar 

  54. Bonometti R, Sacchi MC, Stobbione P, et al. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur Rev Med Pharmacol Sci. 2020;24:9695–7.

    CAS  PubMed  Google Scholar 

  55. Li Z-X, Zeng S, Wu H-X, Zhou Y. The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis. Clin Exp Med. 2019;19:23–36.

    Article  CAS  PubMed  Google Scholar 

  56. Gianfrancesco M, Hyrich KL, Al-Adely S, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020;79:859–66.

    Article  CAS  PubMed  Google Scholar 

  57. Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Akiyama S, Hamdeh S, Micic D, Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2020;80(3):384–91.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, AIIMS, New Delhi, India

    Rudra Prosad Goswami & Uma Kumar

Authors
  1. Rudra Prosad Goswami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Uma Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India

    Anant Mohan

  2. Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India

    Saurabh Mittal

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Goswami, R.P., Kumar, U. (2022). Rheumatological Complications Following COVID-19. In: Mohan, A., Mittal, S. (eds) Post COVID-19 Complications and Management. Springer, Singapore. https://doi.org/10.1007/978-981-19-4407-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-4407-9_11

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-4406-2

  • Online ISBN: 978-981-19-4407-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation